BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7517584)

  • 21. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
    Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
    J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802].
    Arnett KL; Adams EJ; Gumperz JE; Darke C; Marsh SG; Gelsthorpe K; Parham P
    Tissue Antigens; 1995 Oct; 46(4):316-21. PubMed ID: 8560451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro mutagenesis of HLA-B27: single and multiple amino acid substitutions at consensus B27 sites identify distinct monoclonal antibody-defined epitopes.
    el-Zaatari FA; Taurog JD
    Hum Immunol; 1992 Apr; 33(4):243-8. PubMed ID: 1379218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA class I self peptides isolated from a T-cell leukemia reveal the allele-specific motif of HLA-B38.
    Colovai AI; Suciu-Foca N; Baiulescu GE; Harris PE
    Tissue Antigens; 1994 Aug; 44(2):65-72. PubMed ID: 7817380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-B*0702 antibody epitopes are affected indirectly by distant antigen residues.
    McCutcheon JA; Smith KD; Valenzuela A; Aalbers K; Lutz CT
    Hum Immunol; 1993 Feb; 36(2):69-75. PubMed ID: 7681814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural heterogeneity in HLA-B70, a high-frequency antigen of black populations.
    Domena JD; Little AM; Madrigal AJ; Hildebrand WH; Johnston-Dow L; du Toit E; Bias WB; Parham P
    Tissue Antigens; 1993 Nov; 42(5):509-17. PubMed ID: 8146861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells.
    Madrigal JA; Belich MP; Benjamin RJ; Little AM; Hildebrand WH; Mann DL; Parham P
    J Exp Med; 1991 Nov; 174(5):1085-95. PubMed ID: 1940790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 16th IHIW: a website for antibody-defined HLA epitope Registry.
    Duquesnoy RJ; Marrari M; da M Sousa LC; de M Barroso JR; de S U Aita KM; da Silva AS; do Monte SJ
    Int J Immunogenet; 2013 Feb; 40(1):54-9. PubMed ID: 23136897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ME1 epitope of HLA-B27 confers class I-mediated modulation of gram-negative bacterial invasion.
    Kapasi K; Inman RD
    J Immunol; 1994 Jul; 153(2):833-40. PubMed ID: 7517424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-B73: an atypical HLA-B molecule carrying a Bw6-epitope motif variant and a B pocket identical to HLA-B27.
    Vilches C; de Pablo R; Herrero MJ; Moreno ME; Kreisler M
    Immunogenetics; 1994; 40(2):166. PubMed ID: 7517915
    [No Abstract]   [Full Text] [Related]  

  • 32. A comprehensive approach for typing the alleles of the HLA-B locus by automated sequencing.
    Petersdorf EW; Hansen JA
    Tissue Antigens; 1995 Aug; 46(2):73-85. PubMed ID: 7482511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A transposable epitope of HLA-B7, B40 molecules.
    Ways JP; Lawlor DA; Wan AM; Parham P
    Immunogenetics; 1987; 25(5):323-8. PubMed ID: 2437025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cytotoxic monoclonal human hybridoma antibody (TrJ3) against HLA-B44(12) and -B45(12).
    Ge J; Bratlie A; Hannestad K
    Tissue Antigens; 1992 May; 39(5):258-61. PubMed ID: 1384167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A small test of a sequence-based typing method: definition of the B*1520 allele.
    Domena JD; Little AM; Arnett KL; Adams EJ; Marsh SG; Parham P
    Tissue Antigens; 1994 Oct; 44(4):217-24. PubMed ID: 7871522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.
    Ugolotti E; Vanni I; Raso A; Benzi F; Malnati M; Biassoni R
    Hum Immunol; 2011 Oct; 72(10):859-68. PubMed ID: 21664941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-B*4907 and B*490101 differs by residue 163 placed in a dominant serologic epitope.
    Balas A; García-Sánchez F; Vicario JL
    Tissue Antigens; 2010 Mar; 75(3):286-7. PubMed ID: 20047642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New human leukocyte antigen risk allele in Japanese patients with Takayasu arteritis.
    Takamura C; Ohhigashi H; Ebana Y; Isobe M
    Circ J; 2012; 76(7):1697-702. PubMed ID: 22664757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA typing of HLA-B gene in Takayasu's arteritis.
    Yoshida M; Kimura A; Katsuragi K; Numano F; Sasazuki T
    Tissue Antigens; 1993 Aug; 42(2):87-90. PubMed ID: 7903491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.